Data
Markets
Stocks
Indices
Events Calendar
Economy
Economic Indicators
Economic Calendar
Yield Curve
Funds
Mutual Funds
ETFs
CEFs
Featured Content
Economic Summary Deck
Economic Summary Deck
Earnings Hub
Tariff Deck
Tools
Monitor
Dashboard
Watchlists
Alerts
News
Visualize
Fundamental Chart
Scatter Plot
Technical Chart
Report
Report Builder
Talking Points
Email Reports
Research
Stock Screener
Fund Screener
Comp Tables
Timeseries Analysis
Excel
Sectors
Investment Strategies
Manage
Portfolios
Custom Securities
Scenarios
Portfolio Optimizer
Featured Content
Fund Flows Reports
Fund Flows Reports
AI Chat
Risk Profiles
Support
Resources
Tutorials
FAQs
Integrations
Financial Glossary
Info
About Us
Contact Us
Product Release Notes
Content
Webinars
Case Studies
Insights & Visuals
Blog
Featured Content
Top 10 Visuals Deck
Top 10 Visuals Deck
Portfolio Rebalancing Guide
YCharts University Training
Plans
Cancel
Free Trial
Log In

CRISPR Therapeutics AG (CRSP)

37.10 -0.43 (-1.15%) USD  |  NASDAQ  |  May 23, 15:45
Reports
 Actions
Notes
Add to Watchlist
More

CRISPR Therapeutics Unrealized Gain (Loss) on Investment Securities (Quarterly)

View 4,000+ Financial Data Types:
Add
Browse

Unrealized Gain (Loss) on Investment Securities (Quarterly) Chart

View Unrealized Gain (Loss) on Investment Securities (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Quarterly) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals Inc --
Novartis AG --
Roche Holding AG --
Alcon Inc --
Sandoz Group AG --
Quickflows
CRSP
Settings